Another Tool for your Diversion Monitoring Toolkit

Another Tool for your Diversion Monitoring Toolkit

Ever wondered how artificial intelligence could help tackle drug diversion in healthcare? In this episode of 'Drug Diversion Insights', Terri Vidals sits down with Christopher Malter, the CEO of Avalon AI, to explore this very question. With the opioid crisis putting immense pressure on healthcare systems, finding effective ways to monitor and prevent drug diversion has never been more critical. Traditional methods often fall short, but Avalon AI's cutting-edge technology promises to change that.

Christopher explains how their platform focuses on real-time monitoring, initially targeting orthopedic procedures but with the potential to expand into other areas. This innovative approach doesn't just detect diversion; it aims to improve patient outcomes as well. Christopher describes Avalon AI as a 'better mousetrap', offering a more efficient and reliable solution compared to conventional methods. If you're curious about how AI can make a difference in healthcare, this episode is a must-listen.